1-6 of 6
Mayur Narkhede, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features, Treatments and Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma: A Single-Center Experience

Tylan Magnusson, MD, Greer Burkholder, MD, Nathan Erdmann, MD PhD, Amitkumar Mehta, MD, Mayur Narkhede, MD, Gaurav Goyal, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20.
https://doi.org/10.1182/blood-2020-143253
Published: 2020
Journal Articles

Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)

Mayur Narkhede, MD, Sadaf Qureshi, MD, Maryam Yazdy, MD, Roxanna Juarez, MD, Giuseppe Esposito, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1720.
https://doi.org/10.1182/blood-2018-99-113791
Published: 2018
Journal Articles

External Validation and Revision of Thrombosis Lymphoma /Throly/ Score

Darko Antic, PhD, Natasa Milic, Biljana Mihaljevic, Bruce Cheson, MD, Mayur Narkhede, MD, Hikmat Abdel-Razeq, Irina Panovska, Sanja Trajkova, Marija Popova, Igor Aurer, Ana Boban, Michele Ghielmini, Alden Moccia, Aurelien Delluc, Jean-Christophe Ianotto, Ulrich Jaeger, MD, Cathrin Skrabs, Grigorios T. Gerotziafas, Jawed Fareed, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 140.
https://doi.org/10.1182/blood-2018-99-115568
Published: 2018
Journal Articles

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Darrko Antic, Mihaljevic Biljana, Natasa Milic, Bruce D. Cheson, MD, Mayur Narkhede, MD, Irina Panovska, Sanja Trajkova, Marija Popova, Pilar Llamas, MDPhD, Arantxa Garcías Raso, Aurelien Delluc, MD PhD, Jean-Christophe Ianotto, MD, Grigorios T. Gerotziafas, MD PhD, Jawed Fareed, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 558.
https://doi.org/10.1182/blood.V130.Suppl_1.558.558
Published: 2017
Journal Articles

Effect of Early Non-Hematologic Treatment Toxicity on Complete Remission (CR) and Time to CR in Acute Myeloid Leukemia Patients Undergoing Remission Induction Chemotherapy

Surbhi Sidana, MD, Mayur Narkhede, MD, Tomas Radivoyevitch, PhD, Moshe C. Ornstein, MD MA, Cassandra Fincher, Amanda L. Maggiotto, BS, CCRP, Yogen Saunthararajah, MD, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Betty K. Hamilton, MD, Matt E. Kalaycio, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD MPH
Journal: Blood
Blood (2014) 124 (21): 2279.
https://doi.org/10.1182/blood.V124.21.2279.2279
Published: 2014
Journal Articles

Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy

Mayur Narkhede, MD, Jason Valent, MD, Chad Cummings, MBA, Katherine Glass, MPH, MS, Debbie Hastings, Beth Faiman, PhD, CNP, Kimberly Hamilton, CNP, Janice Reed, RN, Mary Ann Karam, RN, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Mitchell R. Smith, MD PhD, Hien K. Duong, MD, Christy Samaras, DO, Frederic J. Reu, MD
Journal: Blood
Blood (2014) 124 (21): 2620.
https://doi.org/10.1182/blood.V124.21.2620.2620
Published: 2014